I-Corps: System for Sampling of Powder Blends in Pharmaceutical Manufacturing
I-Corps: System for Sampling of Powder Blends in Pharmaceutical Manufacturing
批准号:
1659082
负责人:
Rodolfo Romanach
金额:
$5.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-11-01 至 2018-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The broader impact/commercial potential of this I-Corps project will be realized first in pharmaceutical manufacturing where powder blends are required to prepare tablets. The new sampler will bring products to market in less time providing benefit to patients and pharmaceutical companies. The proposed device (sampler) will potentially protect employees in pharmaceutical plants from exposure to potentially toxic drugs. It will potentially be useful across a wide variety of industries and be suitable for powder blends such as vitamins, nutraceuticals, powdered milk, and other food products. The sampler will improve quality control and potentially lead to representative sampling in quality control, thereby reducing risk to customers and patients.This I-Corps project will define the essential components and features for sampling powders in pharma and food manufacturing applications. The current technology does not provide representative samples from these important commercial products. Current approaches use a spear (thief sampler) to obtain samples from only a few pre-selected locations within the manufacturing equipment, and will typically fail to detect variations or problems outside of these locations. The spear also often alters the composition of the material that is sampled, providing inaccurate measurements of the composition of the powdered product. The new device will be based on best practices first established within the mining industry, which have not been adapted to the pharmaceutical and food industries due to lack of suitable sampling devices. The goal of the I-corps project is to develop powder sampling methods to improve the quality of powder based products, and avoid unnecessary product loss due to poor sampling practices.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
TOS MEETS THE NSF I-CORPS™ PROGRAM
TOS 符合 NSF I-CORPS™ 计划
DOI:
--
发表时间:
2017
期刊:
Australi
影响因子:
--
作者:
[Pinzon, C., Rodriguez, V., Hormaza, M. L., Romañach, R.J.]
通讯作者:
Romañach, R.J.
HSI Conference: Accelerating the Impact of HSI STEM Education and Research on Innovation Ecosystems
-
批准号:1802552
-
项目类别:Standard Grant
-
资助金额:$10.0万
-
财政年份:2018
-
负责人:Rodolfo Romanach
-
依托单位:
MRI: Acquisition of NIR Chemical Imaging Spectrometer to Study Novel Organic Composites
-
批准号:0821113
-
项目类别:Standard Grant
-
资助金额:$29.08万
-
财政年份:2008
-
负责人:Rodolfo Romanach
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于铁死亡探讨黄芪甲苷调控System/Xc-/GSH/GPX4信号通路在神经损伤性勃起功能障碍治疗中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:马轲
-
依托单位:
Data-driven Recommendation System Construction of an Online Medical Platform Based on the Fusion of Information
-
批准号:--
-
项目类别:外国青年学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:江洋子
-
依托单位:
TBX1/LKB1轴阻断system Xc活性调控AML细胞铁死亡的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:
-
依托单位:
TET2通过调控BAP1-System Xc-轴促进紫拉非尼诱导的肝细胞癌铁死亡的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:--
-
依托单位:
P3H1通过ATF4/System Xc-轴抑制肾癌铁死亡和抗肿瘤免疫反应的作用及机制研究
-
批准号:82372704
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:王保军
-
依托单位:
基于PNO1介导system Xc-/GSH途径调控肠上皮细胞自噬依赖性铁死亡探讨加味胶七散治疗溃疡性结肠炎的机制
-
批准号:82304982
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘伟萍
-
依托单位:
基于单细胞测序探讨淫羊藿苷对Erastin诱导髓核细胞铁死亡相关system-Xc/GSH/GPX4分子轴线的调控作用
-
批准号:82360947
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2023
-
负责人:张彦军
-
依托单位:
内皮细胞机械敏感离子通道Piezo1通过HIF-1α/system Xc-介导BBB破坏在急性脑缺血再灌注损伤中的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:王德任
-
依托单位:
miR-198 靶向 Nrf2 抑制 System Xc-通路调控滋养细胞铁死亡在子痫前期中的机制
-
批准号:2022JJ70123
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:阳双健
-
依托单位:
BAP1介导H2B去泛素化抑制System Xc-在蛛网膜下腔出血神经元铁死亡中的作用和机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:李明昌
-
依托单位: